Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
23.13
-1.17 (-4.81%)
At close: Mar 9, 2026, 4:00 PM EDT
23.50
+0.37 (1.60%)
After-hours: Mar 9, 2026, 7:53 PM EDT

Company Description

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services.

This segment also offers consultation services to clients throughout their experimental design and implementation processes.

The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services.

The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space.

The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.

Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Azenta, Inc.
Azenta logo
Country United States
Founded 1978
IPO Date Feb 1, 1995
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 3,000
CEO John P. Marotta

Contact Details

Address:
200 Summit Drive, 6th Floor
Burlington, Massachusetts 01803
United States
Phone 888 229 3682
Website azenta.com

Stock Details

Ticker Symbol AZTA
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year October - September
Reporting Currency USD
CIK Code 0000933974
CUSIP Number 114340102
ISIN Number US1143401024
Employer ID 04-3040660
SIC Code 3559

Key Executives

Name Position
John P. Marotta President, Chief Executive Officer and Director
Lawrence Y. Lin Executive Vice President and Chief Financial Officer
Ephraim Starr Senior Vice President, General Counsel and Corporate Secretary
Olga Pirogova Senior Vice President and Chief Human Resources Officer
Dr. Ginger Zhou Ph.D. Senior Vice President and President of GENEWIZ
Michael Paulo Vice President, Chief Information and Digital Officer
Yvonne Perron Vice President of Financial Planning and Analysis and Investor Relations
Dr. Andrea O'Hara Ph.D. Strategic Technical Specialist of Azenta Life Sciences
Alex Esmon Vice President and General Manager of Sample Repository Solutions

Latest SEC Filings

Date Type Title
Mar 4, 2026 8-K Current Report
Feb 5, 2026 10-Q Quarterly Report
Feb 4, 2026 8-K Current Report
Feb 2, 2026 8-K Current Report
Jan 29, 2026 8-K Current Report
Jan 21, 2026 SCHEDULE 13G/A Filing
Dec 29, 2025 8-K Current Report
Dec 19, 2025 DEFR14A Filing
Dec 19, 2025 ARS Filing
Dec 18, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material